Griffith University

  • Griffith Portal
  • Contact us
  • Current students
    • Ask us (current students)
    • Careers and employment
    • Fees and charges
    • Griffith Portal
    • Learning@Griffith
    • Library
    • New students
    • Programs and courses
    • Student email
    • Timetables
  • Current staff
    • Griffith Portal
    • IT support
    • Learning and teaching
    • Learning@Griffith
    • Library
    • Research
    • Staff resources
    • Staff email
  • Future students
    • Future Students
    • International students
    • Degree finder
    • Scholarships
    • How do I apply
    • Financing your degree
    • Important dates
  • About Griffith
    • About the University
    • Campuses
    • Schools and centres
    • Fast facts
    • Life at Griffith
    • Learning and teaching
    • Employment at Griffith
    • Sustainability
  • Research
    • Griffith research
    • Research centres
    • Research excellence
    • Research expertise
    • Research students
    • Griffith Enterprise
    • Research services
  • Alumni
    • Benefits and services
    • Giving to Griffith
    • Inspiring alumni
    • Online donations
    • Staff Alumni
Home > Professional page > Associate Professor George Mellick > Publications

Publications

  • Popular links
      • Learning@Griffith
      • Degree Finder
      • Student Email
      • Timetables
      • IT Helpdesk
      • Ask Us a question
      • Summer semester
      • Admissions
       
      With over 50,000 students, 5 campuses and research that's solving the problems of the world, there's a lot going on at our university. If you can't find the answer you're looking for at these popular links, we can answer your question at Ask us.
 
  • Associate Professor George Mellick
  • Curriculum vitae
  • Publications

Journal articles

  1. Sharma, M., Maraganore, D.M., Ioannidis, J.P., Riess, O., Aasly, J.O., Annesi, G., Mellick, G.D., et al., Role of sepiapterin reductase gene at the PARK3 locus in Parkinson disease. Neurobiology of Aging (Ms. No.: NBA-10-832R1), Accepted 2011.
  2. Lehn, A.C., Mellick, G. and Boyle, R., Teaching NeuroImages: Neuroferritinopathy. Neurology (MS ID#: NEUROLOGY/2011/391805), Accepted 2011.
  3. Matheson, S., G., B., Dissanayaka, N., Pachana, N., Mellick, G., O’Sullivan, J., Silburn, P., Sellbach, A. and Marsh, R., Validity and reliability of the Geriatric Anxiety Inventory in Parkinson’s disease. Australasian Journal on Ageing AAJA-2010-106.R1., Accepted 2010. In Press.
  4. Manathunga, C., Pitt, R., Cox, L., Boreham, P., Mellick, G.D., Lant, P. and Critchley, C., Evaluating industry-based doctoral research programs: perspectives and outcomes of Australian Cooperative Research Centre graduates. Studies in Higher Education CSHE-2010-0487., Accepted 2010. In Press.
  5. Sutherland, G.T., Siebert, G.A., Kril, J.J. and Mellick, G.D., Knowing Me, Knowing You: Can Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease? J Alzheimers Dis 2011.
  6. Saad, M., Lesage, S., Saint-Pierre, A., Corvol, J.C., Zelenika, D., Lambert, J.C., Vidailhet, M., Mellick, G.D., et al., Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet 2011. 20(3): 615-27.
  7. Mellick, G.D. and Ross, O.A., Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions? Eur J Neurol 2011. 18(5): 671-2.
  8. Kruger, R., Sharma, M., Riess, O., Gasser, T., Van Broeckhoven, C., Theuns, J., Aasly, J., Annesi, G., Mellick, G.D., et al., A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging 2011. 32(3): 548 e9-18.
  9. Evangelou, E., Maraganore, D.M., Annesi, G., Brighina, L., Brice, A., Elbaz, A., Ferrarese, C., Hadjigeorgiou, G.M., Krueger, R., Lambert, J.C., Lesage, S., Markopoulou, K., Mellick, G.D., Meeus, B., Pedersen, N.L., Quattrone, A., Van Broeckhoven, C., Sharma, M., Silburn, P.A., Tan, E.K., Wirdefeldt, K. and Ioannidis, J.P., Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet 2011. 153B(1): 220-8.
  10. Elbaz, A., Ross, O.A., Ioannidis, J.P., Soto-Ortolaza, A.I., Moisan, F., Aasly, J., Annesi, G., Bozi, M., Brighina, L., Chartier-Harlin, M.C., Destee, A., Ferrarese, C., Ferraris, A., Gibson, J.M., Gispert, S., Hadjigeorgiou, G.M., Jasinska-Myga, B., Klein, C., Kruger, R., Lambert, J.C., Lohmann, K., van de Loo, S., Loriot, M.A., Lynch, T., Mellick, G.D., et al., Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol 2011. 69(5): 778-792.
  11. Dissanayaka, N.N., Sellbach, A., Silburn, P.A., O'Sullivan, J.D., Marsh, R. and Mellick, G.D., Factors associated with depression in Parkinson's disease. J Affect Disord 2011. 132(1-2): 82-8.
  12. Dissanayaka, N.N., Sellbach, A., Matheson, S., O'Sullivan, J.D., Silburn, P.A., Byrne, G.J., Marsh, R. and Mellick, G.D., Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2011. 25(7): 838-45.
  13. White, N., Johnson, H., Silburn, P., Mellick, G., Dissanayaka, N. and Mengersen, K., Probabilistic subgroup identification using Bayesian finite mixture modelling: A case study in Parkinson's disease phenotype identification. Stat Methods Med Res 2010.
  14. Mellick, G.D., Silburn, P.A., Sutherland, G.T. and Siebert, G.A., Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities. Expert Rev Mol Diagn 2010. 10(8): 1035-1050.
  15. Matigian, N., Abrahamsen, G., Sutharsan, R., Cook, A.L., Vitale, A.M., Nouwens, A., Bellette, B., An, J., Anderson, M., Beckhouse, A.G., Bennebroek, M., Cecil, R., Chalk, A.M., Cochrane, J., Fan, Y., Feron, F., McCurdy, R., McGrath, J.J., Murrell, W., Perry, C., Raju, J., Ravishankar, S., Silburn, P.A., Sutherland, G.T., Mahler, S., Mellick, G.D., Wood, S.A., Sue, C.M., Wells, C.A. and Mackay-Sim, A., Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech 2010. 3(11-12): 785-98.
  16. Evangelou, E., Maraganore, D.M., Annesi, G., Brighina, L., Brice, A., Elbaz, A., Ferrarese, C., Hadjigeorgiou, G.M., Krueger, R., Lambert, J.C., Lesage, S., Markopoulou, K., Mellick, G.D., Meeus, B., Pedersen, N.L., Quattrone, A., Van Broeckhoven, C., Sharma, M., Silburn, P.A., Tan, E.K., Wirdefeldt, K. and Ioannidis, J.P., Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet 2010. 153B(1): 220-8.
  17. Dissanayaka, N.N., Sellbach, A., Matheson, S., O'Sullivan, J.D., Silburn, P.A., Byrne, G.J., Marsh, R. and Mellick, G.D., Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010. 25(7): 838-45.
  18. Sutherland, G.T., Siebert, G.A., Newman, J.R., Silburn, P.A., Boyle, R.S., O'Sullivan, J.D. and Mellick, G.D., Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease. Mov Disord 2009. 24(3): 449-52.
  19. Sutherland, G.T., Matigian, N.A., Chalk, A.M., Anderson, M.J., Silburn, P.A., Mackay-Sim, A., Wells, C.A. and Mellick, G.D., A cross-study transcriptional analysis of Parkinson's disease. PLoS One 2009. 4(3): e4955.
  20. Sutherland, G.T., Halliday, G.M., Silburn, P.A., Mastaglia, F.L., Rowe, D.B., Boyle, R.S., O'Sullivan, J.D., Ly, T., Wilton, S.D. and Mellick, G.D., Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? Mov Disord 2009. 24(6): 833-8.
  21. Mellick, G.D., Siebert, G.A., Funayama, M., Buchanan, D.D., Li, Y., Imamichi, Y., Yoshino, H., Silburn, P.A. and Hattori, N., Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. Parkinsonism Relat Disord 2009. 15(2): 105-9.
  22. Mehta, P., Mellick, G.D., Rowe, D.B., Halliday, G.M., Jones, M.M., Manwaring, N., Vandebona, H., Silburn, P.A., Wang, J.J., Mitchell, P. and Sue, C.M., Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community. Mov Disord 2009. 24(2): 290-2.
  23. Haehner, A., Boesveldt, S., Berendse, H.W., Mackay-Sim, A., Fleischmann, J., Silburn, P.A., Johnston, A.N., Mellick, G.D., Herting, B., Reichmann, H. and Hummel, T., Prevalence of smell loss in Parkinson's disease--a multicenter study. Parkinsonism Relat Disord 2009. 15(7): 490-4.
  24. Dissanayaka, N.N., Silburn, P.A., O'Sullivan, J.D. and Mellick, G.D., Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease. Mov Disord <strong>2009. 24(1): 111-5.
  25. Dissanayaka, N.N., Sellebach, A.N., Matheson, S., Marsh, R., O'Sullivan, J.D., Silburn, P.A., Byrne, G.J. and Mellick, G.D., Validity of a self-rated method to identify a lifetime history of depression in Parkinson's disease. Mov Disord 2009. 24(16): 2435-8.
  26. Sutherland, G., Mellick, G., Newman, J., Double, K.L., Stevens, J., Lee, L., Rowe, D., Silburn, P. and Halliday, G.M., Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2008. 147B(4): 495-9.
  27. Silburn, P.A., Mellick, G.D., Vieira, B.I., Danta, G., Boyle, R.S. and Herawati, L., Utility of a patient survey in identifying fluctuations in early stage Parkinson's disease. J Clin Neurosci 2008. 15(11): 1235-9.
  28. Chapuis, J., Moisan, F., Mellick, G., Elbaz, A., Silburn, P., Pasquier, F., Hannequin, D., Lendon, C., Campion, D., Amouyel, P. and Lambert, J.C., Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease. Hum Mol Genet, 2008. 17(18): 2863-7.
  29. Sutherland, G.; Mellick, G.; Sue, C.; Chan, D. K.; Rowe, D.; Silburn, P.; Halliday, G. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease. Neurosci Lett 2007, 414, 170-3.
  30. Mo, Y. K.; Kankavi, O.; Masci, P. P.; Mellick, G. D.; Whitehouse, M. W.; Boyle, G. M.; Parsons, P. G.; Roberts, M. S.; Cross, S. E. Surfactant protein expression in human skin: evidence and implications. J Invest Dermatol 2007, 127, 381-6.
  31. Mellick, G. D. TNF gene polymorphism and quantitative traits related to cardiovascular disease: getting to the heart of the matter. Eur J Hum Genet 2007, 15, 609-11.
  32. Manathuga, C.; Lant, P.; Mellick, G. Developing professional independent researchers: research students' graduate attributes. Studies in Continuing Education 2007, 29, In Press.
  33. Huang, Y.; Halliday, G. M.; Vandebona, H.; Mellick, G. D.; Mastaglia, F.; Stevens, J.; Kwok, J.; Garlepp, M.; Silburn, P. A.; Horne, M. K.; Kotschet, K.; Venn, A.; Rowe, D. B.; Rubio, J. P.; Sue, C. M. Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease. Mov Disord 2007, 22, 982-9.
  34. Dissanayaka, N. N.; Sellbach, A.; Matheson, S.; Marsh, R.; Silburn, P. A.; O'Sullivan, J. D.; Byrne, G. J.; Mellick, G. D. Validity of Hamilton Depression Inventory in Parkinson's disease. Mov Disord 2007, 22, 399-403.
  35. Buchanan, D. D.; Silburn, P. A.; Prince, J. A.; Mellick, G. D. Association of APOE with Parkinson disease age-at-onset in women. Neurosci Lett 2007, 411, 185-8.
  36. Sellbach, A. N.; Boyle, R. S.; Silburn, P. A.; Mellick, G. D. Parkinson's disease and family history. Parkinsonism Relat Disord 2006, 12, 399-409.
  37. Peters, C. M.; Gartner, C. E.; Silburn, P. A.; Mellick, G. D. Prevalence of Parkinson's disease in metropolitan and rural Queensland: a general practice survey. J Clin Neurosci 2006, 13, 343-8.
  38. Motsinger, A. A.; Lee, S. L.; Mellick, G.; Ritchie, M. D. GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease. BMC Bioinformatics 2006, 7, 39.
  39. Mellick, G. D.; Gartner, C. E.; Silburn, P. A.; Battistutta, D. Passive smoking and Parkinson disease. Neurology 2006, 67, 179-80.
  40. Mellick, G. D. CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key. J Neural Transm Suppl 2006, 159-65.
  41. Maraganore, D. M.; de Andrade, M.; Elbaz, A.; Farrer, M. J.; Ioannidis, J. P.; Kruger, R.; Rocca, W. A.; Schneider, N. K.; Lesnick, T. G.; Lincoln, S. J.; Hulihan, M. M.; Aasly, J. O.; Ashizawa, T.; Chartier-Harlin, M. C.; Checkoway, H.; Ferrarese, C.; Hadjigeorgiou, G.; Hattori, N.; Kawakami, H.; Lambert, J. C.; Lynch, T.; Mellick, G. D.; Papapetropoulos, S.; Parsian, A.; Quattrone, A.; Riess, O.; Tan, E. K.; Van Broeckhoven, C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. Jama 2006, 296, 661-70.
  42. Manathuga, C.; Lant, P.; Mellick, G. Imagining an interdisciplinary doctoral pedagogy. Teaching in Higher Education 2006, 11, 365-379.
  43. Elbaz, A.; Nelson, L. M.; Payami, H.; Ioannidis, J. P.; Fiske, B. K.; Annesi, G.; Carmine Belin, A.; Factor, S. A.; Ferrarese, C.; Hadjigeorgiou, G. M.; Higgins, D. S.; Kawakami, H.; Kruger, R.; Marder, K. S.; Mayeux, R. P.; Mellick, G. D.; Nutt, J. G.; Ritz, B.; Samii, A.; Tanner, C. M.; Van Broeckhoven, C.; Van Den Eeden, S. K.; Wirdefeldt, K.; Zabetian, C. P.; Dehem, M.; Montimurro, J. S.; Southwick, A.; Myers, R. M.; Trikalinos, T. A. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol 2006, 5, 917-23.
  44. Coyne, T.; Silburn, P.; Cook, R.; Silberstein, P.; Mellick, G.; Sinclair, F.; Fracchia, G.; Wasson, D.; Stanwell, P. Rapid subthalamic nucleus deep brain stimulation lead placement utilising CT/MRI fusion, microelectrode recording and test stimulation. Acta Neurochir Suppl 2006, 99, 49-50.
  45. Corder, E. H.; Mellick, G. D. Parkinson's disease in relation to pesticide exposure and nuclear encoded mitochondrial complex I gene variants. J Biomed Biotechnol 2006, 2006, 27601.
  46. Mellick, G. D.; Maraganore, D. M.; Silburn, P. A. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease. Neurosci Lett 2005, 375, 112-6.
  47. Kwok, J. B.; Hallupp, M.; Loy, C. T.; Chan, D. K.; Woo, J.; Mellick, G. D.; Buchanan, D. D.; Silburn, P. A.; Halliday, G. M.; Schofield, P. R. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann Neurol 2005, 58, 829-39.
  48. Gartner, C. E.; Battistutta, D.; Dunne, M. P.; Silburn, P. A.; Mellick, G. D. Test-retest repeatability of self-reported environmental exposures in Parkinson's disease cases and healthy controls. Parkinsonism Relat Disord 2005, 11, 287-95.
  49. Whitbread, A. K.; Mellick, G. D.; Silburn, P. A.; Le Couteur, D. G.; Board, P. G. Glutathione transferase Omega class polymorphisms in Parkinson disease. Neurology 2004, 62, 1910-1.
  50. Mellick, G. D.; Silburn, P. A.; Prince, J. A.; Brookes, A. J. A novel screen for nuclear mitochondrial gene associations with Parkinson's disease. J Neural Transm 2004, 111, 191-9.
  51. Mellick, G.; Price, L.; Boyle, R. Late-onset presentation of pyruvate dehydrogenase deficiency. Mov Disord 2004, 19, 727-9.
  52. Maraganore, D. M.; Lesnick, T. G.; Elbaz, A.; Chartier-Harlin, M. C.; Gasser, T.; Kruger, R.; Hattori, N.; Mellick, G. D.; Quattrone, A.; Satoh, J.; Toda, T.; Wang, J.; Ioannidis, J. P.; de Andrade, M.; Rocca, W. A. UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 2004, 55, 512-21.
  53. Kwok, J. B.; Teber, E. T.; Loy, C.; Hallupp, M.; Nicholson, G.; Mellick, G. D.; Buchanan, D. D.; Silburn, P. A.; Schofield, P. R. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol 2004, 55, 329-34.
  54. Deng, Y.; Newman, B.; Dunne, M. P.; Silburn, P. A.; Mellick, G. D. Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease. Ann Neurol 2004, 55, 897.
  55. Deng, Y.; Newman, B.; Dunne, M. P.; Silburn, P. A.; Mellick, G. D. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci Lett 2004, 366, 326-31.
  56. Chan, D. K.; Cordato, D.; Bui, T.; Mellick, G.; Woo, J. Comparison of environmental and genetic factors for Parkinson's disease between Chinese and Caucasians. Neuroepidemiology 2004, 23, 13-22.
  57. Blomqvist, M. E.; Silburn, P. A.; Buchanan, D. D.; Andreasen, N.; Blennow, K.; Pedersen, N. L.; Brookes, A. J.; Mellick, G. D.; Prince, J. A. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. Neurogenetics 2004, 5, 115-9.
  58. Chan, D. K.; Mellick, G. D.; Hung, W. T.; Woo, J. Genetic and environmental risk factors and their interactions for Parkinson's disease in a Chinese population. J Clin Neurosci 2003, 10, 313-5.
  59. Le Couteur, D. G.; Muller, M.; Yang, M. C.; Mellick, G. D.; McLean, A. J. Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev Environ Health 2002, 17, 51-64.
  60. Chan, D. K.; Mellick, G. D.; Buchanan, D. D.; Hung, W. T.; Ng, P. W.; Woo, J.; Kay, R. Lack of association between CYP1A1 polymorphism and Parkinson's disease in a Chinese population. J Neural Transm 2002, 109, 35-9.
  61. Buchanan, D. D.; Silburn, P. A.; Chalk, J. B.; Le Couteur, D. G.; Mellick, G. D. The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients. Neurosci Lett 2002, 327, 91-4.
  62. Taylor, M. C.; Board, P. G.; Blackburn, A. C.; Mellick, G. D.; Le Couteur, D. G. Zeta class glutathione transferase polymorphisms and Parkinson's disease. J Neurol Neurosurg Psychiatry 2001, 70, 407.
  63. Mellick, G. D.; Buchanan, D. D.; Hattori, N.; Brookes, A. J.; Mizuno, Y.; Le Couteur, D. G.; Silburn, P. A. The parkin gene S/N167 polymorphism in Australian Parkinson's disease patients and controls. Parkinsonism Relat Disord 2001, 7, 89-91.
  64. Taylor, M. C.; Le Couteur, D. G.; Mellick, G. D.; Board, P. G. Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population. J Neural Transm 2000, 107, 979-83.
  65. Mellick, G. D.; Silburn, P. A. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease. Neurosci Lett 2000, 293, 127-30.
  66. Mellick, G. D.; Buchanan, D. D.; Silburn, P. A.; Chan, D. K.; Le Couteur, D. G.; Law, L. K.; Woo, J.; Pang, C. P. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population. J Neurol 2000, 247, 52-5.
  67. McCann, S. J.; McManus, M. E.; Johnson, A. G.; Mellick, G. D.; Le Couteur, D. G.; Pond, S. M. The serotonin transporter gene and Parkinson's disease. Eur Neurol 2000, 44, 108-11.
  68. Foster, K. A.; Mellick, G. D.; Weiss, M.; Roberts, M. S. An isolated in-situ rat head perfusion model for pharmacokinetic studies. Pharm Res 2000, 17, 127-34.
  69. Chan, D. K.; Mellick, G.; Cai, H.; Wang, X. L.; Ng, P. W.; Pang, C. P.; Woo, J.; Kay, R. The alpha-synuclein gene and Parkinson disease in a Chinese population. Arch Neurol 2000, 57, 501-3.
  70. Mellick, G. D.; Roberts, M. S. Structure-hepatic disposition relationships for phenolic compounds. Toxicol Appl Pharmacol 1999, 158, 50-60.
  71. Mellick, G. D.; McCann, S. J.; Le Couter, D. G. Parkinson's disease, MAOB, and smoking. Neurology 1999, 53, 658.
  72. Mellick, G. D.; Buchanan, D. D.; McCann, S. J.; James, K. M.; Johnson, A. G.; Davis, D. R.; Liyou, N.; Chan, D.; Le Couteur, D. G. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord 1999, 14, 219-24.
  73. Mellick, G. D.; Buchanan, D. D.; McCann, S. J.; Davis, D. R.; Le Couteur, D. G.; Chan, D.; Johnson, A. G. The ACE deletion polymorphism is not associated with Parkinson's disease. Eur Neurol 1999, 41, 103-6.
  74. Macdonald, G. A.; Tarish, J.; Whitehall, V. J.; McCann, S. J.; Mellick, G. D.; Buttenshaw, R. L.; Johnson, A. G.; Young, J.; Leggett, B. A. No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation. J Gastroenterol Hepatol 1999, 14, 1188-91.
  75. Le Couter, D. G.; McLean, A. J.; Blackburn, A. C.; Mellick, G. D.; Board, P. G. Glutathione transferase polymorphism and Parkinson's disease. Lancet 1999, 353, 71-72.
  76. Menegon, A.; Board, P. G.; Blackburn, A. C.; Mellick, G. D.; Le Couteur, D. G. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998, 352, 1344-6.
  77. Hung, D. Y.; Mellick, G. D.; Whitehead, B. D.; Roberts, M. S. The effect of protein binding on the hepatic first pass of O-acyl salicylate derivatives in the rat. J Pharm Pharmacol 1998, 50, 63-9.
  78. Hung, D. Y.; Mellick, G. D.; Masci, P. P.; Whitaker, A. N.; Whitehouse, M. W.; Roberts, M. S. Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats. J Lab Clin Med 1998, 132, 469-77.
  79. Hung, D. Y.; Mellick, G. D.; Anissimov, Y. G.; Weiss, M.; Roberts, M. S. Hepatic disposition and metabolite kinetics of a homologous series of diflunisal esters. J Pharm Sci 1998, 87, 943-51.
  80. Hung, D. Y.; Mellick, G. D.; Anissimov, Y. G.; Weiss, M.; Roberts, M. S. Hepatic structure-pharmacokinetic relationships: the hepatic disposition and metabolite kinetics of a homologous series of O-acyl derivatives of salicylic acid. Br J Pharmacol 1998, 124, 1475-83.
  81. Mellick, G. D.; Roberts, M. S. Impulse-response studies on tracer doses of [14C]lignocaine and its multiple metabolites in the perfused rat liver. J Pharm Pharmacol 1997, 49, 1008-18.
  82. Mellick, G. D.; Anissimov, Y. G.; Bracken, A. J.; Roberts, M. S. Metabolite mean transit times in the liver as predicted by various models of hepatic elimination. J Pharmacokinet Biopharm 1997, 25, 477-505.
  83. Hung, D. Y.; Mellick, G. D.; Prankerd, R. J.; Roberts, M. S. Synthesis, identification, characterization, stability, solubility and protein binding of ester derivatives of salicylic acid and diflunisal. International Journal of Pharmaceutics 1997, 153, 25-39.
  84. Mellick, G. D.; Roberts, M. S. The disposition of aspirin and salicylic acid in the isolated perfused rat liver: the effect of normal and retrograde flow on availability and mean transit time. J Pharm Pharmacol 1996, 48, 738-43.
  85. Mellick, G. D. Studies on the disposition of solutes in the perfused rat liver and the influence of physicochemical properties. Doctoral thesis, University of Queensland. 1996.
  86. Mellick, G. D.; Roberts, M. S. Use of a solute-container interaction to determine protein binding: application to long-chain fatty acids. J Pharm Sci 1993, 82, 1067-8.
  87. Mellick, G. D. Picolinate and catecholate models for iron (III) ferreascidin. BSc (Hons) Thesis, The University of Queensland. 1990.

First peoples.

Aboriginal and Torres Strait Islander

  • Feedback
  • Privacy policy
  • Copyright matters
  • CRICOS Provider - 00233E
Gold Coast • Logan • Brisbane | Australia

Explore Griffith

Current students

  • Ask us (current students)
  • Griffith Portal
  • Learning@Griffith
  • New students
  • Programs and courses
  • Student email
  • Library

Current staff

  • Computing
  • Griffith Portal
  • IT support
  • Learning and teaching
  • Library
  • New staff
  • Staff email

Future students

  • Future students
  • International students
  • Degree finder
  • Scholarships
  • How do I apply
  • Financing your degree
  • Important dates

About Griffith

  • About the University
  • Campuses
  • Schools and centres
  • Fast facts
  • Life at Griffith
  • Learning and teaching
  • Employment at Griffith
  • Sustainability

Research

  • Griffith research
  • Research centres
  • Research excellence
  • Research expertise
  • Research students
  • Griffith Enterprise
  • Research services

Alumni

  • Benefits and services
  • Giving to Griffith
  • Inspiring alumni
  • Staff Alumni

Study areas

  • Business and commerce
  • Criminology and law
  • Education
  • Engineering and IT
  • Environment, planning and architecture
  • Health
  • Humanities and languages
  • Music
  • Science and aviation
  • Visual and creative arts

Information for

  • Guidance Officers
  • Higher degree by research
  • Indigenous students
  • International students
  • Media
  • Non-school leavers
  • Parents and guardians
  • Postgraduate students
  • School students
  • TAFE and tertiary pathways
view mode Standard :: Mobile